UBS Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.74M | Sell |
|
|||||
|
2025
Q2 | $2.05M | Buy |
|
|||||
|
2025
Q1 | $4.32M | Buy |
|
|||||
|
2024
Q4 | $7.16M | Buy |
|
|||||
|
2024
Q3 | $6.25M | Sell |
|
|||||
|
2024
Q2 | $8.74M | Sell |
|
|||||
|
2024
Q1 | $13.7M | Buy |
|
|||||
|
2023
Q4 | $1.28M | Sell |
|
|||||
|
2023
Q3 | $5.29M | Buy |
|
|||||
|
2023
Q2 | $545K | Sell |
|
|||||
|
2023
Q1 | $1.99M | Sell |
|
|||||
|
2022
Q4 | $5.78M | Buy |
|
|||||
|
2022
Q3 | $1.55M | Buy |
|
|||||
|
2022
Q2 | $919K | Sell |
|
|||||
|
2022
Q1 | $2.76M | Buy |
|
|||||
|
2021
Q4 | $3.07M | Buy |
|
|||||
|
2021
Q3 | $2.87M | Buy |
|
|||||
|
2021
Q2 | $539K | Sell |
|
|||||
|
2021
Q1 | $3.29M | Buy |
|
|||||
|
2020
Q4 | $2.53M | Buy |
|
|||||
|
2020
Q3 | $461K | Buy |
|
|||||
|
2020
Q2 | $64K | Sell |
|
|||||
|
2020
Q1 | $425K | Sell |
|
|||||
|
2019
Q4 | $1.28M | Buy |
|
|||||
|
2019
Q3 | $610K | Buy |
|
|||||
|
2019
Q2 | $84K | Buy |
|
|||||
|
2019
Q1 | $0 | Sell |
|
|||||
|
2018
Q4 | $267K | Buy |
|
|||||
|
2018
Q3 | $123K | Buy |
|
|||||
|
2018
Q2 | $71K | Buy |
|
|||||
|
2018
Q1 | $29K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $0 | Sell |
|
|||||
|
2017
Q1 | $1K | Sell |
|
|||||
|
2016
Q4 | $17K | Buy |
|
|||||
|
2016
Q3 | $13K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $286K | Buy |
|
|||||
|
2015
Q4 | $1K | Sell |
|
|||||
|
2015
Q3 | $51K | Sell |
|
|||||
|
2015
Q2 | $31K | Buy |
|
|||||
|
2015
Q1 | $5K | Buy |
|